How did the private labs fit onto COVID-19 crisis?

被引:1
作者
Galhaud, Jean-Philippe [1 ]
Scherrer, Florian [2 ]
Kemeny, Stephan [3 ]
Beauvieux, Marie-Christine [4 ,5 ]
Delevallee, Celine [3 ]
机构
[1] Grp Labexa, Le Hailian, France
[2] LBM Syniab Vallee Rhone, Grp Syniab, Roussillon, France
[3] LBM Gen Bio, Grp Inovie, Clermont Ferrand, France
[4] CHU Bordeaux, Serv Biochim, Bordeaux, France
[5] Univ Bordeaux, RMSB, UMR 5536, CNRS, Bordeaux, France
关键词
COVID-19; SARS CoV-2; private medical laboratories; pandemia; health crisis;
D O I
10.1684/abc.2020.1608
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Confronted with the COVID-19 crisis, healthcare professionals have had to tackle an epidemic crisis of a huge magnitude for which they were not prepared. Medical laboratories have been on the front line, from collecting samples to performing the analysis required to diagnose this new pathology. Responding to the needs and to the urgency of the situation, the authorities relied on the network of private laboratories. In France, private laboratory medicine represents 70% of overall activity, and with a network of more than 4.000 local laboratories, private laboratory medicine has been the cornerstone of the "screen-trace-isolate" strategy. Ibis article gives feedback from private laboratory medicine professionals, directly involved in the reorganization carried out at the pre-analytical, analytical and post-analytical stages, during the crisis from March to October 2020.
引用
收藏
页码:609 / 616
页数:8
相关论文
共 3 条
  • [1] SFBC working group "Biochemical markers or COVID-19"
    Beauvieux, Marie-Christine
    Berard, Annie M.
    Aimone-Gastin, Isabelle
    Barbe, Francoise
    Barguil, Yann
    Collin-Chavagnac, Delphine
    Delacour, Herve
    Delevallee, Celine
    Nivet-Antoine, Valerie
    Peoc'h, Katell
    Poupon, Carole
    Schmitt, Francois
    Pieroni, Laurence
    Sapin, Vincent
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 2020, 78 (03) : 269 - 277
  • [2] MINSANTE/ CORRUS, 2020, ACT DOCTR PRIOR TEST, P157
  • [3] MINSANTE/ CORRUS, 2020, PRIOR IND TESTS VIR, P150